R. N. Ratnaike

Postgraduate medical journal · 2003

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Who trusts R. N. Ratnaike overall

  1. Zeeshanur Rahman
  2. M. Kampa
  3. EngD John T. O’Connor

Papers from R. N. Ratnaike's perspective

Ordered by how strongly the researchers R. N. Ratnaike trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.
  2. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. (Journal of Clinical Oncology)
  3. Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
  4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. (New England Journal of Medicine)
  5. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. (Blood)
  6. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. (Blood)
  7. Rituximab dose-escalation trial in chronic lymphocytic leukemia. (Journal of Clinical Oncology)
  8. The fundamental role of epigenetic events in cancer (Nature reviews genetics)
  9. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. (Blood)
  10. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. (Blood)

Their papers